Disease Overview：Hypertension（HTN）
Hypertension, or essential arterial hypertension, is a chronic cardiovascular condition characterized by persistently elevated systemic arterial pressure—typically defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg on repeated measurements. Left unmanaged, it significantly increases the risk of stroke, myocardial infarction, heart failure, chronic kidney disease, and vascular dementia. Diagnosis involves comprehensive clinical evaluation—including ambulatory blood pressure monitoring, echocardiography, renal function assessment, and lipid profiling—to differentiate primary (idiopathic) from secondary causes such as renal artery stenosis or endocrine disorders. Management emphasizes individualized, evidence-based strategies: lifestyle modification (DASH diet, sodium restriction, aerobic exercise), pharmacotherapy (ACE inhibitors, calcium channel blockers, thiazide diuretics, ARBs), and long-term adherence monitoring via telehealth-enabled follow-up.
China offers distinct advantages for international patients seeking hypertension care. Its tier-3 hospitals—many accredited by JCI or ISO—house nationally recognized cardiologists with extensive experience in complex hypertension phenotyping and resistant hypertension management. Advanced diagnostic tools, including 3T cardiac MRI, invasive hemodynamic assessment, and genetic testing for monogenic hypertension syndromes, are widely available. Clinical outcomes align with global benchmarks: over 85% of patients achieve target BP control within six months under structured multidisciplinary programs. Crucially, treatment costs in China average 40–60% lower than in the US or Western Europe—without compromising quality—due to streamlined healthcare financing and domestic pharmaceutical innovation. As a dedicated medical tourism agency, we facilitate seamless access: pre-travel eligibility screening, direct referrals to top-tier cardiovascular centers, transparent all-inclusive pricing (covering diagnostics, consultations, medications, and accommodation), and bilingual concierge support—from visa assistance to post-discharge telemonitoring coordination.
Hypertension: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Hypertension (Cardiovascular Department)
Non-Surgical / Conservative Management
*Target Criteria:* Stage 1–2 hypertension (SBP 130–179 mmHg or DBP 80–109 mmHg), no end-organ damage, or as adjunct to pharmacotherapy.
- •Lifestyle Intervention Program (3-month package)
- 6 sessions of supervised dietary counseling (low-sodium, DASH protocol) + physical activity prescription: $180 - Home BP monitoring kit (validated upper-arm device) + digital log platform access: $45 *Total Tier 1 (Mild, <55 y/o, no comorbidities): $345*
- •First-Line Pharmacotherapy (Annual, Generic Formulations)
- Telmisartan 40 mg daily × 365 days: $38 - Annual labs (renal function, electrolytes, fasting glucose, lipid panel): $75 - Biannual follow-up visits (cardiologist, BP check, adherence review): $110 *Total Tier 2 (Stage 2, age 55–74, stable T2DM or CKD stage 1–2): $245/year*
Surgical / Procedural Intervention
*Eligibility Criteria:* Resistant hypertension (≥3 drugs including diuretic at max tolerated doses, SBP >140 mmHg despite adherence), confirmed secondary causes (e.g., renal artery stenosis ≥70% on CTA/MRA), no contraindications to angiography.
- •Renal Artery Stenting (percutaneous transluminal angioplasty + stent)
- Procedure (stent implantation, fluoroscopy-guided, single vessel): $3,200–$4,100 - Post-procedure 24-hr ICU observation + antiplatelet therapy (clopidogrel × 30 days): $480 *Total Range: $3,900–$4,790*
Special/Complex Condition Management
- •Primary Aldosteronism (confirmed via saline infusion test + adrenal CT)
- Pre-op adrenal vein sampling (AVS): $1,350
- •Aortic Coarctation Repair (hypertension secondary to congenital narrowing)
- Pre-op aortic MRI + catheter-based pressure gradient measurement: $1,020
Quick Selection Guide
- •<55 years, SBP <140 mmHg, no comorbidities: Start with Tier 1 lifestyle program ($345) — cost-effective first-line.
- •Age 60–75, Stage 2 HTN + T2DM: Tier 2 pharmacotherapy ($245/year) + annual renal labs — optimal safety and adherence balance.
- •Resistant HTN + renal artery stenosis ≥70%: Renal stenting ($3,900–$4,790) — definitive intervention with proven BP reduction.
- •Confirmed unilateral aldosteronoma: Laparoscopic adrenalectomy ($4,800–$5,600) — curative for ~60% of cases; superior long-term outcomes vs. spironolactone.
- •Young adult (<40) with severe HTN + pulse delay/claudication: Aortic coarctation workup → endovascular repair ($6,200–$7,400) if anatomy suitable.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hypertension Medical Vacation Packages
Curated transparent all-inclusive packages combining Hypertension treatment with China top medical destinations:
